Department: Quality (QC/QA) | Production API
Qualifications : B.Sc / M.Sc Chemistry
Pass Outs Year : 2022, 2023,2024 Only (Final Year Marksheet of Highest Qualification is Mandatory)
Job Description :
Familiar with Basic Organic & Analytical Chemistry Concepts.
Handling of Instruments/Equipment.
Completion of tasks/activities as per SOPs & comply to cGMP, GxP & other regulatory compliance.
Review and Preparation of various documents.
Knowledge of Chromatography Instruments.
Good English Communication Skill (Oral & Written).
Must be ready to Work in Shift.
Note :
Minimum 60% in the Highest Qualification.
Candidates who have given interview in last 06 Months are not eligible.
Stipend for B.Sc. -11000/-
Stipend for M.Sc. - . 12,000/-
Register yourself on this link https://shorturl.at/KUfou
&
Share CV on - parichaymdp@lupin.com
Lupin's journey serves as a tribute to the creative potential, empathy, and undying desire for a better tomorrow in humankind. Since its founding in 1968 by the visionary Dr. Desh Bandhu Gupta, Lupin has grown from modest beginnings to become a pioneer in the world of healthcare. With our headquarters in Mumbai, India, we have grown throughout the United States, Latin America, Asia, and Europe. We now operate in more than 100 countries and provide a wide range of products, numbering in the thousands. Lupin is steadfast in its pursuit of its goal of ensuring that everyone has access to high-quality healthcare, drawing inspiration from the hardy lupin flower that thrives in harsh environments and nourishes the earth. We understand how critical it is to support the communities we work with and make a constructive contribution to society.
Lupin's extensive global manufacturing network enables us to provide our clients with products that are guaranteed to be of high quality. The objective of producing quality, reasonably priced medications that fulfill unmet patient requirements is shaped by our investments in manufacturing capital. We keep increasing automation and capacity to support our pipeline of sophisticated generics and biotechnology items in accordance with our growth strategy.
The high-potency product manufacturing block at Indore Unit I, the cutting-edge Metered Dose Inhalers (MDI) plant at Indore Unit III, the Pyrazinamide API block at the Visakhapatnam unit, the new, cutting-edge facility for Oral Solid Dose (OSD) formulations and injectables at the Nagpur SEZ unit, and the multiplication of our Biotech Drug Substance facility in Pune are just a few of the new areas we have recently created capacities in.